MXJ:PA:PA- (EUR)

ETF | Others |

Last Closing

USD 12.498

Change

-0.06 (-0.45)%

Market Cap

USD 0.50B

Volume

4.99K
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.06 (-0.13%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.60 (+0.31%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.31%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.65 (-0.27%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.15 (+0.48%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.15 (+0.30%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.16 (+0.35%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.27%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.46 (+0.40%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

+0.53 (+0.50%)

USD 4.29B

ETFs Containing MXJ:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.92% 32% F 53% F
Dividend Return N/A 80% B- 60% D-
Total Return N/A 89% A- 99% N/A
Trailing 12 Months  
Capital Gain 4.45% 28% F 53% F
Dividend Return N/A 74% C 21% F
Total Return N/A 50% F 48% F
Trailing 5 Years  
Capital Gain -1.08% 24% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.08% 22% F 37% F
Average Annual (5 Year Horizon)  
Capital Gain 1.28% 29% F 39% F
Dividend Return N/A 61% D- 8% B-
Total Return N/A 68% D+ 74% C
Risk Return Profile  
Volatility (Standard Deviation) N/A 72% C 88% B+
Risk Adjusted Return N/A 13% F 86% B+
Market Capitalization 0.50B 69% C- 70% C-

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.